John D. Lopinski

John’s practice includes patent and opinion work, and strategic development and management of patent portfolios. He focuses on molecular biology, CRISPR-based technologies, virology and immunology, complex immunotherapies, cancer biology, and biologics for use in a wide range of human and non-human animal disorders. Prior to law school, John developed and taught courses in cell and molecular biology in the University at Buffalo’s School of Medicine and Biomedical Sciences post-baccalaureate program, which is designed to expand the pool of underrepresented, economically and educationally disadvantaged students in medical school. John completed his doctoral degree in what was then the SUNY Buffalo Center for Advanced Molecular Biology and Immunology, while simultaneously enrolled at SUNY Buffalo Law School. John graduated from law school with honors and was also a co-founding editor of the Buffalo Intellectual Property Law Journal. His research has been published in peer-reviewed scientific journals and has been cited more than 100 times by other scientists in high-impact publications.

John assists a wide variety of clients with intellectual property needs, including large, publicly traded companies and smaller, privately held corporations. He especially enjoys working with university technology transfer offices and their faculty and is a long-standing member of the Association of University Technology Managers (AUTM), where he serves on the Eastern Regional Meeting planning committee. John practices in the firm’s Buffalo and New York City offices, and provides patent services from its Silver Spring, Maryland, office.* He exclusively practices U.S. law and is admitted in New York and to the U.S. Patent and Trademark Office.